⚠ Evidence note: Mechanistic aging biology translates to human interventions slowly and unreliably; model-organism lifespan gains have repeatedly failed to transfer.
CISD2 Longevity Pathway
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-09-23 — A probioticconverts hesperidin to bioactive hesperetin and improves metabolic dysfunction in aging mice.: 2026 aging-mouse (Western diet) study: oral probiotic strain CL256B, which bioconverts dietary hesperidin to hesperetin, engaged the CISD2 longevity pathway and improved body composition, hepatic steatosis, and grip strength — first in vivo demonstration that a microbiome-delivered flavonoid metabolite can activate CISD2 in a naturally aging mammal, preclinical only. [animal-model] (novelty: 3)
Open questions
Related
Contributing findings
A probioticconverts hesperidin to bioactive hesperetin and improves metabolic dysfunction in aging mice.
23-sep-2026
novelty 3
per-area 3
strengthens